| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Aug 25 | S | 14,036 | $2.21 | $31K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Aug 18 | S | 484 | $2.01 | $973 |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Aug 18 | S | 1,229 | $2.01 | $2K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | May 21 | F | 13,729 | $1.79 | $25K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | May 18 | A | 72,706 | $0.00 | — |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | May 18 | A | 180,095 | $0.00 | — |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | May 14 | F | 490 | $1.92 | $941 |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | May 14 | F | 1,253 | $1.92 | $2K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEODERIVJOINT | Mar 1 | A | 185,495 | $0.00 | —? |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEODERIVJOINT | Mar 1 | A | 417,210 | $0.00 | —? |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Feb 21 | F | 14,265 | $1.53 | $22K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Feb 14 | F | 579 | $1.63 | $944 |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Feb 14 | F | 1,302 | $1.63 | $2K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Jan 14 | P | 49,000 | $1.68 | $82K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Nov 21 | F | 19,904 | $2.30 | $46K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Nov 14 | F | 490 | $2.24 | $1K |
| Acrivon Therapeutics, Inc. | ACRV | Peter Blume-JensenCEOJOINT | Nov 14 | F | 59,765 | $2.24 | $134K |